MacroGenics, Inc. (NASDAQ:MGNX) Receives Consensus Rating of "Buy" from Analysts

Retrieved on: 2021-04-05 06:22:30

Tags for this article:

Click the tags to see associated articles and topics

MacroGenics, Inc. (NASDAQ:MGNX) Receives Consensus Rating of "Buy" from Analysts. View article details on hiswai:

Excerpt

Morgan Stanley lifted their price target on MacroGenics from $14.00 to $15.00 and gave the stock an "underweight" rating in a report on Thursday, ...

Article found on: www.marketbeat.com